Detection in colorectal carcinoma patients of antibody cytotoxic to established cell strains derived from carcinoma of the human colon and rectum

Sera from eight of 15 patients with colonic carcinoma exhibited demonstrable cytotoxicity against an established cell strain derived from adenocarcinoma of the ileocecum, HCT‐8. Sera from 12 of 16 patients with rectal carcinoma were cytotoxic for an established cell strain derived from an adenocarcinoma of the rectum, HRT‐18. Patients with colonic carcinoma exhibited serum cytotoxicity against only the colonic target cells, whereas patients with rectal carcinoma gave significant cytotoxicity against both cell strains. This cytotoxicity was shown to be complement‐dependent and appeared to be specific for colonic and/or rectal carcinoma cells. Although the cells produced carcinoembryonic antigen (CEA) in vitro, the cytotoxic antibody response in these patients did not appear to be directed against CEA. Serum cytotoxicity was not demonstrated against two other cell strains, HCT‐48 and HT‐29, derived from adenocarcinomas of the human colon, except for a reaction against a blood‐group‐related antigen. These cell strains had comparable levels of cell‐associated CEA. The routine titration of cytotoxic antibody against these established cell cultures may provide meaningful information on the host's immune response to colorectal neoplasms.

[1]  K. Irie,et al.  Evidence for in vivo Reaction of Antibody and Complement to Surface Antigens of Human Cancer Cells , 1974, Science.

[2]  R M Schultz,et al.  Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. , 1974, Journal of the National Cancer Institute.

[3]  M. Williams,et al.  Immunity to Colon Cancer Assessed by Antigen-Induced Inhibition of Mixed Mononuclear Cell Migration , 1973, Science.

[4]  J. Fahey,et al.  Anti‐tumor activity in human serum: Antibodies detecting blood‐group‐A‐like antigen on the surface of tumor cells in culture , 1973, International journal of cancer.

[5]  M. Price,et al.  Inhibition of cell mediated cytotoxicity against human colon carcinomata by papain-solubilized tumour membrane extracts. , 1973, British Journal of Cancer.

[6]  R. Herberman,et al.  Separation of Skin Reactive Intestinal Cancer Antigen from the Carcinoembryonic Antigen of Gold , 1972, Science.

[7]  G. Klein,et al.  Cellular reactions against Burkitt lymphoma cells. I. Colony inhibition with effector cells from patients with Burkitt's lymphoma , 1972, International journal of cancer.

[8]  E. Bloom Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture. , 1972, Cancer research.

[9]  E. Hughes,et al.  Immunological Reactivity in Patients with Carcinoma of Colon , 1971, British medical journal.

[10]  N. Cascinelli,et al.  Cellular and humoral immunity against human malignant melanoma , 1971, International journal of cancer.

[11]  D. Morton,et al.  Microcytotoxicity Test: Detection in Sarcoma Patients of Antibody Cytotoxic to Human Sarcoma Cells , 1970, Science.

[12]  K. Hellström,et al.  Cell‐mediated immunity against antigens common to human colonic carcinomas and fetal gut Epithelium , 1970, International journal of cancer.

[13]  K. Hellström,et al.  Studies on cellular immunity to human neuroblastoma cells , 1970, International journal of cancer.

[14]  E. Bloom Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene. , 1970, Journal of the National Cancer Institute.

[15]  D. Morton,et al.  Sarcoma-specific antigens: detection by complement fixation with serum from sarcoma patients. , 1970, Journal of the National Cancer Institute.

[16]  P. Perlmann,et al.  Immune response to urinary bladder tumours in man , 1970, International journal of cancer.

[17]  K. Hellström,et al.  Cellular and Humoral immunity to Different Types of Human Neoplasms , 1968, Nature.

[18]  I. Hellstrom,et al.  Demonstration of cell-bound and humoral immunity against neuroblastoma cells. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Henle,et al.  Complement-Fixation Tests with Cell Lines Derived from Burkitt's Lymphoma and Acute Leukemias , 1966, Journal of bacteriology.

[20]  Phil Gold,et al.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES , 1965, The Journal of experimental medicine.